FdaApplication
NDA 021527
Identifiers
- fda_app_no: NDA021527
Properties
| Property | Value |
|---|---|
| applicant_name | BOEHRINGER INGELHEIM PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2004-11-27 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ATROVENT HFA | IPRATROPIUM BROMIDE | 0.021MG/INH | AEROSOL, METERED;INHALATION |
1 product